Neurocrine Biosciences Ratios (2010-2026) | NBIX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)	98.93%	98.58%	98.69%	98.52%	76.00%	98.43%	98.13%	97.98%	97.46%	97.75%	98.35%	98.54%	98.44%	98.71%	98.52%	98.39%	98.36%	98.24%	97.82%	98.31%
EBT Margin (Quarter)	19.90%	10.30%	-4.42%	6.89%	-116.50%	25.24%	28.62%	-24.57%	26.86%	23.18%	38.47%	6.70%	16.71%	30.59%	25.90%	2.57%	23.20%	36.71%	29.72%	30.30%
EBIT Margin (Quarter)	21.74%	15.03%	-11.63%	1.00%	273.50%	22.63%	25.10%	-27.16%	16.26%	28.31%	29.17%	19.27%	24.64%	29.55%	22.62%	4.12%	21.18%	30.07%	26.18%	23.74%
EBITDA Margin (Quarter)	14.54%	7.50%	-3.01%	2.03%	-99.00%	17.20%	23.08%	-16.98%	21.45%	16.54%	30.36%	7.70%	10.88%	22.79%	15.04%	1.94%	16.15%	26.44%	19.07%	22.74%
Operating Margin (Quarter)	21.74%	15.03%	-11.63%	1.00%	273.50%	22.63%	25.10%	-27.16%	16.26%	28.31%	29.17%	19.27%	24.64%	29.55%	22.62%	4.12%	21.18%	30.07%	26.18%	23.74%
Net Margin (Quarter)	14.64%	7.60%	-2.34%	4.48%	-84.50%	17.66%	21.60%	-18.22%	21.10%	16.66%	28.67%	8.42%	11.01%	20.86%	16.43%	1.38%	15.64%	26.36%	19.08%	24.30%
FCF Margin (Quarter)	36.52%	16.72%	5.38%	-15.49%	646.50%	29.52%	30.87%	-29.92%	36.43%	45.39%	18.65%	25.07%	7.27%	24.10%	37.47%	9.45%	13.02%	31.46%	44.07%	16.78%
Efficiency
Inventory Average (Quarter)	29.20M	26.90M	28.00M	29.75M	29.15M	33.15M	36.05M	34.25M	32.55M	30.25M	33.55M	37.75M	39.85M	44.15M	51.60M	58.25M	58.00M	63.10M	69.15M	66.75M
Assets Average (Quarter)	1,901.40M	1,986.85M	2,044.90M	2,108.50M	2,075.10M	2,074.55M	2,256.05M	2,364.25M	2,486.45M	2,730.65M	3,049.80M	3,361.90M	3,388.70M	3,420.00M	3,626.85M	3,703.20M	3,788.75M	4,077.75M	4,448.60M	4,768.85M
Equity Average (Quarter)	1,242.40M	1,312.60M	1,360.00M	1,382.55M	1,407.25M	1,484.00M	1,626.20M	1,696.15M	1,768.75M	1,927.55M	2,117.05M	2,309.05M	2,447.65M	2,614.05M	2,654.30M	2,562.70M	2,615.00M	2,848.95M	3,128.35M	3,330.25M
Invested Capital (Quarter)	1,279.20M	1,346.00M	1,374.00M	1,391.10M	1,423.40M	1,713.80M	1,877.20M	1,684.50M	2,022.70M	2,172.00M	2,402.10M	2,508.90M	2,509.20M	2,718.90M	2,589.70M	2,535.70M	2,694.30M	3,003.60M	3,253.10M	3,407.40M
Asset Utilization Ratio (Quarter)	0.54	0.54	0.55	0.57	0.45	0.50	0.50	0.52	0.67	0.65	0.62	0.59	0.63	0.66	0.65	0.65	0.66	0.66	0.64	0.65
Leverage & Solvency
Interest Coverage Ratio (Quarter)	10.13	6.74	-5.50	1.19	24.86	73.17	94.00	-103.82	56.62	128.36	136.64	90.27
Debt to Equity (Quarter)						0.11	0.10		0.09	0.08	0.08	0.05
Debt Ratio (Quarter)						0.08	0.07		0.06	0.06	0.05	0.04
Equity Ratio (Quarter)	0.65	0.67	0.66	0.65	0.71	0.72	0.72	0.71	0.71	0.70	0.69	0.69	0.76	0.77	0.70	0.69	0.69	0.70	0.70	0.69
Times Interest Earned (Quarter)	10.13	6.74	-5.50	1.19	24.86	73.17	94.00	-103.82	56.62	128.36	136.64	90.27
Valuation
Enterprise Value (Quarter)	-884.90M	-765.90M	-714.50M	-664.90M	-648.30M	-799.40M	-997.10M	-894.60M	-976.70M	-1095.10M	-1039.60M	-1210.60M	-1038.90M	-1228.00M	-1076.10M	-943.50M	-975.60M	-1114.80M	-1480.40M	-1316.20M
Return Ratios
Return on Sales (Quarter)	0.00%	0.00%	0.00%	0.00%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Capital Employed (Quarter)	7.21%	11.96%	5.70%	3.99%	3.69%	6.88%	14.49%	6.62%	7.91%	10.00%	10.48%	17.53%	17.93%	19.36%	18.29%	15.56%	15.27%	16.00%	16.71%	20.04%
Return on Invested Capital (Quarter)	0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Research Tools

Neurocrine Biosciences Ratios (2010-2026) | NBIX

Create an account

Sign In

Reset Password